Clinical Trial Update: Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children [Phase 3]

View source ↗

Summary

A Phase 3 trial of 0.01% atropine eye drops for near-work-induced transient myopia in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Atropine Sulfate Eye Drops 0.01% (atropine sulfate)

Snippet

Sponsor: Ocumension Therapeutics (Suzhou) Co., Ltd | Conditions: Myopia | Phase 3 | Status: COMPLETED